Advertisement
News
Advertisement

InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation

Mon, 06/27/2011 - 7:32am
Bio-Medicine.Org

TEL-AVIV, Israel, June 27, 2011 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced it has signed a distribution agreement with IMPLANTA, a well-established Moscow-based supplier to medical centers throughout the Russian Federation.

Under terms of the agreement, ZAO Implanta will work to use its distribution network in the Russian Federation for the sale of InspireMD's MGuard™ coronary stent systems. ZAO Implanta is one of the major medical instrumentations and stent distributors in the Russian Federation and has representative offices in various regions and cities, including Vladivostok, Nizhny Novgorod, St. Petersburg, Samara, Yekaterinburg, Novosibirsk and Krasnodar. MGuard was launched at the 13th Moscow International Course on Vascular Diagnosis and Treatment of Congenital and Acquired Heart Diseases in Bakulev, Moscow.  The Bakulev Scientific Center of Cardiovascular Surgery is one of the leading cardiovascular surgery-related facilities of the Russian Federation.

Sara Alon-Paz, Vice President of Sales of InspireMD commented, "As we continue to validate our technology, including the randomized trial currently underway, we are simultaneously building a world-class distribution network to position us to capture market share in the future. Adding a proven distributor like ZAO Implanta, with more than a dozen years in the market and a reputation for distributing the newest medical technologies, is in-line with our vision. We are excited about the potential in the Russian Federation market, and look forward to penetrating this growing region's market as we complete validation studies."

“IMPLANTA has a history of selecting the newest, unique and most advanced, technologies for distribution and we are excited to continue this by adding MGuard to our portfolio,” commented Mr. Petr A. Gukovskiy,

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading